This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Jun;19(6):716-717.

doi: 10.1016/S1470-2045(18)30270-5. Epub 2018 May 16.

Does a patient's sex predict the efficacy of cancer immunotherapy?

Omar Abdel-Rahman¹

Affiliations

Affiliation

¹ Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary T2N 1N4, AB, Canada. Electronic address: omar.abdelrhman@med.asu.edu.eg.

PMID: 29778735
DOI: 10.1016/S1470-2045(18)30270-5

Comment

Does a patient's sex predict the efficacy of cancer immunotherapy?

Omar Abdel-Rahman. Lancet Oncol. 2018 Jun.

. 2018 Jun;19(6):716-717.

doi: 10.1016/S1470-2045(18)30270-5. Epub 2018 May 16.

Author

Omar Abdel-Rahman¹

Affiliation

¹ Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary T2N 1N4, AB, Canada. Electronic address: omar.abdelrhman@med.asu.edu.eg.

PMID: 29778735
DOI: 10.1016/S1470-2045(18)30270-5

No abstract available

PubMed Disclaimer

Comment on

Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis.
Conforti F, Pala L, Bagnardi V, De Pas T, Martinetti M, Viale G, Gelber RD, Goldhirsch A. Conforti F, et al. Lancet Oncol. 2018 Jun;19(6):737-746. doi: 10.1016/S1470-2045(18)30261-4. Epub 2018 May 16. Lancet Oncol. 2018. PMID: 29778737

Similar articles

Checkpoint immunotherapy for cancer: superior survival, unaccustomed toxicities.
Gedye C, van der Westhuizen A, John T. Gedye C, et al. Intern Med J. 2015 Jul;45(7):696-701. doi: 10.1111/imj.12653. Intern Med J. 2015. PMID: 25444021 Review.
Patient's T cells target tumor mutation.
[No authors listed] [No authors listed] Cancer Discov. 2014 Jul;4(7):751. doi: 10.1158/2159-8290.CD-NB2014-079. Epub 2014 May 29. Cancer Discov. 2014. PMID: 25002594
Mutanome directed cancer immunotherapy.
Vormehr M, Diken M, Boegel S, Kreiter S, Türeci Ö, Sahin U. Vormehr M, et al. Curr Opin Immunol. 2016 Apr;39:14-22. doi: 10.1016/j.coi.2015.12.001. Epub 2015 Dec 21. Curr Opin Immunol. 2016. PMID: 26716729 Review.
Immunoengineering with biomaterials for enhanced cancer immunotherapy.
Xie YQ, Wei L, Tang L. Xie YQ, et al. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018 Jul;10(4):e1506. doi: 10.1002/wnan.1506. Epub 2018 Jan 14. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018. PMID: 29333729 Review.
The swinging pendulum of cancer immunotherapy personalization.
Abraham TS, Snook AE. Abraham TS, et al. Per Med. 2017 May;14(3):259-270. doi: 10.2217/pme-2016-0108. Epub 2017 May 5. Per Med. 2017. PMID: 29767586 Review.

See all similar articles

Cited by

Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data.
Ruggiero R, Stelitano B, Fraenza F, di Mauro G, Scavone C, Sportiello L, Rafaniello C, Di Napoli R, Danesi R, Del Re M, Rossi F, Capuano A. Ruggiero R, et al. Front Oncol. 2022 Mar 15;12:824511. doi: 10.3389/fonc.2022.824511. eCollection 2022. Front Oncol. 2022. PMID: 35372076 Free PMC article.
Sex Differences in Immunity.
Wilkinson NM, Chen HC, Lechner MG, Su MA. Wilkinson NM, et al. Annu Rev Immunol. 2022 Apr 26;40:75-94. doi: 10.1146/annurev-immunol-101320-125133. Epub 2022 Jan 5. Annu Rev Immunol. 2022. PMID: 34985929 Free PMC article. Review.
Neoadjuvant/Perioperative Treatment Affects Spatial Distribution and Densities of Tumor Associated Neutrophils and CD8+ Lymphocytes in Gastric Cancer.
Hoffmann A, Behrens HM, Heckl S, Krüger S, Becker T, Röcken C. Hoffmann A, et al. J Pers Med. 2021 Nov 12;11(11):1184. doi: 10.3390/jpm11111184. J Pers Med. 2021. PMID: 34834537 Free PMC article.
The knowns & unknowns of pulmonary toxicity following immune checkpoint inhibitor therapies: a narrative review.
Miller AR, Manser R. Miller AR, et al. Transl Lung Cancer Res. 2021 Jun;10(6):2752-2765. doi: 10.21037/tlcr-20-806. Transl Lung Cancer Res. 2021. PMID: 34295675 Free PMC article. Review.
Immune Checkpoint Inhibitors and Cardiac Toxicity in Patients Treated for Non-Small Lung Cancer: A Review.
Sławiński G, Wrona A, Dąbrowska-Kugacka A, Raczak G, Lewicka E. Sławiński G, et al. Int J Mol Sci. 2020 Sep 29;21(19):7195. doi: 10.3390/ijms21197195. Int J Mol Sci. 2020. PMID: 33003425 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations